We have located links that may give you full text access.
Clinical Question: In congestive heart failure patients with preserved ejection fraction, does spironolactone improve cardiac outcomes?
Journal of the Oklahoma State Medical Association 2016 September
CLINICAL QUESTION: In congestive heart failure patients with preserved ejection fraction, does spironolactone improve cardiac outcomes?
ANSWER: No. A randomized controlled trial of patients with heart failure and an ejection fraction > 45% showed that spironolactone did not significantly reduce the incidence of the primary composite outcome of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the management of heart failure.
LEVEL OF EVIDENCE FOR THE ANSWER: A.
SEARCH TERMS: Congestive heart failure, Spironolactone, Ejection fraction, Preserved, Mineralocorticoids.
LIMITS: English, Adults, Randomized Controlled Trials, Meta-analysis, and Systematic review.
DATE SEARCH WAS CONDUCTED: December 2015.
INCLUSION CRITERIA: All randomized controlled trials, Meta-analyses, and systematic reviews in patients with congestive heart failure with preserved ejection fractions, who were taking spironolactone, and published in the past 5 years.
EXCLUSION CRITERIA: Age less than eighteen years, Eplerenone.
ANSWER: No. A randomized controlled trial of patients with heart failure and an ejection fraction > 45% showed that spironolactone did not significantly reduce the incidence of the primary composite outcome of death from cardiovascular causes, aborted cardiac arrest, or hospitalization for the management of heart failure.
LEVEL OF EVIDENCE FOR THE ANSWER: A.
SEARCH TERMS: Congestive heart failure, Spironolactone, Ejection fraction, Preserved, Mineralocorticoids.
LIMITS: English, Adults, Randomized Controlled Trials, Meta-analysis, and Systematic review.
DATE SEARCH WAS CONDUCTED: December 2015.
INCLUSION CRITERIA: All randomized controlled trials, Meta-analyses, and systematic reviews in patients with congestive heart failure with preserved ejection fractions, who were taking spironolactone, and published in the past 5 years.
EXCLUSION CRITERIA: Age less than eighteen years, Eplerenone.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app